[1]任惠珠,王珊珊,郑妙艳,等.肾小球基底膜中胶原的合成、降解与糖尿病肾病[J].国际内分泌代谢杂志,2015,(04):252-254.[doi:10.3760/cma.j.issn.1673-4157.2015.04.010]
　Ren Huizhu,Wang Shanshan,Zheng Miaoyan,et al.Synthesis and degradation of collagen in glomerular basement membrane and their associations with diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):252-254.[doi:10.3760/cma.j.issn.1673-4157.2015.04.010]

点击复制

肾小球基底膜中胶原的合成、降解与糖尿病肾病()

分享到：

参考文献/References:

[1]　Nolan CJ，Damm P，Prentki M.Type 2 diabetes across generations：from pathophysiology to prevention and management[J].Lancet， 2011，378（9786）：169-181. 　
[2]　Guariguata L，Whiting DR，Hambleton I，et al.Global estimates of diabetes prevalence for 2013 and projections for 2035[J].Diabetes Res Clin Pract，2014，103（2）：137-149. 　
[3]　Blouza S，Dakhli S，Abid H，et al.Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy[J].J Nephrol，2010，23（4）：415-424. 　
[4]　Sun YM，Su Y，Li J，et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy[J].Biochem Biophys Res Commun，2013，433（4）：359-361. 　
[5]　Maezawa Y，Takemoto M，Yokote K.Cell biology of diabetic nephropathy：roles of endothelial cells，tubulointerstitial cells and podocytes[J].J Diabetes Investig，2015，6（1）：3-15. 　
[6]　Suh JH，Miner JH.The glomerular basement membrane as a barrier to albumin[J].Nat Rev Nephrol，2013，9（8）：470-477. 　
[7]　Ekinci EI，Jerums G，Skene A，et al.Renal structure in normoal-buminuric and albuminuric patients with type 2 diabetes and impaired renal function[J].Diabetes Care，2013，36（11）：3620-3626. 　
[8]　Menon MC，Chuang PY，He CJ.The glomerular filtration barrier：components and crosstalk[J].Int J Nephrol，2012，2012：749010. 　
[9]　Miner JH.Glomerular basement membrane composition and the filtration barrier[J].Pediatr Nephrol，2011，26（9）：1413-1417.
[10]　Byron A，Randles MJ，Humphries JD，et al.Glomerular cell cross-talk influences composition and assembly of extracellular matrix[J].J Am Soc Nephrol，2014，25（5）：953-966.
[11]　Goldberg S，Adair-Kirk TL，Senior RM，et al.Maintenance of glomerular filtration barrier integrity requires laminin alpha5[J].J Am Soc Nephrol，2010，21（4）：579-586.
[12]　Olaru F，Wang XP，Luo W，et al.Proteolysis breaks tolerance toward intact α345（Ⅳ） collagen，eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hex-amers[J].J Immunol，2013，190（4）：1424-1432.
[13]　Bader BL，Smyth N，Nedbal S，et al.Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice[J].Mol Cell Biol，2005，25（15）：6846-6856.
[14]　McCarthy KJ，Wassenhove-McCarthy DJ.The glomerular base-ment membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans [J].Microsc Microanal，2012， 18（1）：3-21.
[15]　Goldberg S，Harvey SJ，Cunningham J，et al.Glomerular filtration is normal in the absence of both agrin and perlecan heparan sulfate from the glomerular basement membrane[J].Nephrol Dial Transplant，2009，24（7）：2044-2051.
[16]　Good DM，Zürbig P，Argilés A，et al.Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease[J].Mol Cell Proteomics，2010，9（11）：2424-2437.
[17]　Zürbig P，Jerums G，Hovind P，et al.Urinary proteomics for early diagnosis in diabetic nephropathy[J].Diabetes，2012，61（12）：3304-3313.
[18]　Taniguchi K，Xia L，Goldberg HJ，et al.Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice[J].Diabetes，2013，62（11）：3874-3886.
[19]　Rabbani N，Thornalley PJ.The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy[J].Diabetes，2014，63（1）：50-52.
[20]　Ma Q，Zhang L，Yao L，et al.Effects of herbal compound 861 on collagen synthesis and degradation in rat mesangial cells exposed to high glucose[J].Chin J Integr Med，2014，20（3）：209-215.
[21]　Liu M，Zhang Y，Chi Y，et al.Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27（kip1） level[J].J Nephrol，2012，25（3）：418-425.
[22]　Li J，Lim SS，Lee JY，et al.Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation：possible renoprotective role in diabetic nephropathy[J].J Nutr Biochem，2012， 23（4）：320-331.
[23]　Elrashidy RA，Asker ME，Mohamed HE.Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy[J].J Cardiovasc Pharmacol Ther，2012，17（3）：324-333.
[24]　Hopps E，Caimi G.Matrix metalloproteinases in metabolic syn-drome[J].Eur J Intern Med，2012，23（2）：99-104.
[25]　Peng L，Yang J，Ning C，et al.Rhein inhibits integrin-linked kinase expression and regulates matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in high glucose-induced epithelial-mesenchymal transition of renal tubular cell [J].Biol Pharm Bull， 2012，35（10）：1676-1685.
[26]　Furukawa M，Gohda T，Hagiwara S，et al.Effect of the ｄirect ｒenin ｉnhibitor ａliskiren on ｕrinary ａlbumin ｅxcretion in ｓponta-neous ｔype 2 ｄiabetic KK-A （y） ｍouse [J].Int J Nephrol，2013， 2013：519130.
[27]　Aggarwal HK，Jain D，Talapatra P，et al.Evaluation of role of doxycycline （a matrix metalloproteinase inhibitor） on renal func-tions in patients of diabetic nephropathy[J]. Ren Fail，2010， 32（8）：941-946.